Works matching IS 00126667 AND DT 2022 AND VI 82 AND IP 7


Results: 10
    1
    2

    PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.

    Published in:
    Drugs, 2022, v. 82, n. 7, p. 719, doi. 10.1007/s40265-022-01703-5
    By:
    • Flippot, Ronan;
    • Patrikidou, Anna;
    • Aldea, Mihaela;
    • Colomba, Emeline;
    • Lavaud, Pernelle;
    • Albigès, Laurence;
    • Naoun, Natacha;
    • Blanchard, Pierre;
    • Terlizzi, Mario;
    • Garcia, Camilo;
    • Bernard-Tessier, Alice;
    • Fuerea, Alina;
    • Di Palma, Mario;
    • Escudier, Bernard;
    • Loriot, Yohann;
    • Baciarello, Giulia;
    • Fizazi, Karim
    Publication type:
    Article
    3
    4
    5

    Pacritinib: First Approval.

    Published in:
    Drugs, 2022, v. 82, n. 7, p. 831, doi. 10.1007/s40265-022-01718-y
    By:
    • Lamb, Yvette N.
    Publication type:
    Article
    6
    7
    8
    9

    Faricimab: First Approval.

    Published in:
    Drugs, 2022, v. 82, n. 7, p. 825, doi. 10.1007/s40265-022-01713-3
    By:
    • Shirley, Matt
    Publication type:
    Article
    10

    Sutimlimab: First Approval.

    Published in:
    Drugs, 2022, v. 82, n. 7, p. 817, doi. 10.1007/s40265-022-01711-5
    By:
    • Dhillon, Sohita
    Publication type:
    Article